Global Patent Index - EP 3697219 A4

EP 3697219 A4 20210714 - METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MAMMALS RESPONSIVE TO OBESITY TREATMENTS

Title (en)

METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MAMMALS RESPONSIVE TO OBESITY TREATMENTS

Title (de)

VERFAHREN UND MATERIALIEN ZUR IDENTIFIZIERUNG UND BEHANDLUNG VON SÄUGETIEREN, DIE AUF ADIPOSITASBEHANDLUNGEN ANSPRECHEN

Title (fr)

PROCÉDÉS ET MATÉRIAUX D'IDENTIFICATION ET DE TRAITEMENT DE MAMMIFÈRES RÉAGISSANT AUX TRAITEMENTS CONTRE L'OBÉSITÉ

Publication

EP 3697219 A4 20210714 (EN)

Application

EP 18867410 A 20181016

Priority

  • US 201762573100 P 20171016
  • US 2018056109 W 20181016

Abstract (en)

[origin: WO2019079317A1] This document provides methods and materials for identifying and treating mammals responsive to obesity treatments. For example, methods and materials for assessing a mammal's gut microbiota (e.g., a human's gut microbiota) to identify that mammal (e.g., human) as being responsive to an obesity treatment are provided. Methods and materials for treating obesity by assessing a mammal's gut microbiota (e.g., a human's gut microbiota) to identify that mammal (e.g., human) as being responsive to an obesity treatment and proceeding with an obesity treatment also are provided.

IPC 8 full level

A61K 35/74 (2015.01); A01N 63/00 (2020.01); A61P 3/04 (2006.01); C12N 1/20 (2006.01); C12Q 1/68 (2018.01); C40B 40/12 (2006.01); G01N 33/53 (2006.01)

CPC (source: EP US)

A61K 35/74 (2013.01 - US); A61K 45/00 (2013.01 - EP); A61K 45/06 (2013.01 - US); A61P 3/04 (2017.12 - EP US); C12N 1/20 (2013.01 - EP); C12Q 1/06 (2013.01 - EP); C12Q 1/6883 (2013.01 - EP); C12Q 1/689 (2013.01 - EP); C12Q 2600/106 (2013.01 - EP); G01N 2800/044 (2013.01 - EP); G01N 2800/52 (2013.01 - EP)

Citation (search report)

  • [X] US 2010172874 A1 20100708 - TURNBAUGH PETER J [US], et al
  • [X] WO 2016049932 A1 20160407 - BGI SHENZHEN CO LTD [CN], et al
  • [X] LOUIS SANDRINE ET AL: "Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing", PLOS ONE, vol. 11, no. 2, 26 February 2016 (2016-02-26), pages e0149564, XP055808698, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769288/pdf/pone.0149564.pdf> DOI: 10.1371/journal.pone.0149564
  • [X] PALLEJA ALBERT ET AL: "Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota", GENOME MEDICINE, vol. 8, no. 1, 1 December 2016 (2016-12-01), XP055809824, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908688/pdf/13073_2016_Article_312.pdf> DOI: 10.1186/s13073-016-0312-1
  • [X] VIRGINIE LECOMTE ET AL: "Changes in Gut Microbiota in Rats Fed a High Fat Diet Correlate with Obesity-Associated Metabolic Parameters", PLOS ONE, vol. 10, no. 5, 18 May 2015 (2015-05-18), pages e0126931, XP055439774, DOI: 10.1371/journal.pone.0126931
  • [X] ZHANG XU ET AL: "Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats", SCIENTIFIC REPORTS, NATURE PUBLISHING GROUP, UK, vol. 5, 1 January 2015 (2015-01-01), pages 14405 - 1, XP009189158, ISSN: 2045-2322
  • [A] F. MORIO ET AL: "Antimicrobial Susceptibilities and Clinical Sources of Dialister Species", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 51, no. 12, 8 October 2007 (2007-10-08), US, pages 4498 - 4501, XP055399577, ISSN: 0066-4804, DOI: 10.1128/AAC.00538-07
  • See references of WO 2019079317A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2019079317 A1 20190425; EP 3697219 A1 20200826; EP 3697219 A4 20210714; US 2021369790 A1 20211202

DOCDB simple family (application)

US 2018056109 W 20181016; EP 18867410 A 20181016; US 201816756458 A 20181016